EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential effects of brexpiprazole on cognitive recovery and cortical lesion volume after experimental traumatic brain injury

Haley E Capeci, Connor E Pivirotto, Jade A Steber, Vincent J Vozzella, Rachel A Bittner, Prajeet Santra, Jeffrey P Cheng, Eleni H Moschonas, Corina O Bondi, Anthony E Kline

Brain Research · 2026-12 · 1892 · 150540

DOI: 10.1016/j.brainres.2026.150540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2026-12. Verfasst von Haley E Capeci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Physical Medicine & Rehabilitation, University of Pittsburgh, Pittsburgh, PA 15213, United States; Safar Center for Resuscitation Research, Universit…. Hauptthemen laut MEDLINE: Thiophenes, Brain Injuries, Traumatic, Quinolones, Recovery of Function. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Managing agitation after traumatic brain injury (TBI) often involves antipsychotic drugs, despite evidence that dopamine D2 antagonists can impair recovery. Brexpiprazole, a third-generation APD with partial agonist activity at dopamine D2 and serotonin 5-HT1A receptors, may provide a safer alternative. To test the hypothesis that brexpiprazole would not hinder recovery and might improve functional outcomes after TBI, anesthetized adult male rats received a controlled cortical impact or sham injury and were treated with brexpiprazole (0.5, 1, or 2 mg/kg, i.p.) or vehicle beginning 24 h post-injury for 21 days. Motor and cognitive performance were assessed during recovery, and cortical lesion volume was measured on day 21. Sham groups did not differ by treatment and were pooled. Relative to vehicle-treated TBI controls, brexpiprazole did not impair motor recovery at any dose. The 0.5 mg/kg dose improved spatial learning, while the 2 mg/kg dose reduced cortical lesion volume (p < 0.05). Memory retention in the 0.5 mg/kg group was comparable to SHAM controls. These findings demonstrate dose-specific behavioral and histological benefits of brexpiprazole following experimental TBI without detectable adverse effects on recovery. Although the mechanisms underlying these effects remain unclear, brexpiprazole warrants further investigation as a treatment option after TBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiophenesBrain Injuries, TraumaticQuinolonesRecovery of FunctionCerebral CortexCognitionAnimalsMaleRats, Sprague-DawleyRatsDisease Models, AnimalMaze LearningDose-Response Relationship, DrugMotor Activity

Stichwörter der Autor:innen

BrexpiprazoleControlled cortical impactFunctional recoveryLearning and memoryMorris water mazeTraumatic brain injury

Substanzen

ThiophenesbrexpiprazoleQuinolones

Autor:innen und Institutionen

  • Physical Medicine & Rehabilitation, University of Pittsburgh, Pittsburgh, PA 15213, United States; Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, PA 15213, United States.
  • Physical Medicine & Rehabilitation, University of Pittsburgh, Pittsburgh, PA 15213, United States; Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, PA 15213, United States; Neurobiology, Un…
  • Physical Medicine & Rehabilitation, University of Pittsburgh, Pittsburgh, PA 15213, United States; Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, PA 15213, United States; Center for Neuro…

Förderung

  • National Institutes of Health

Zitieren

APA

Capeci, H. E., Pivirotto, C. E., Steber, J. A., Vozzella, V. J., Bittner, R. A., Santra, P., Cheng, J. P., Moschonas, E. H., Bondi, C. O., & Kline, A. E. (2026). Differential effects of brexpiprazole on cognitive recovery and cortical lesion volume after experimental traumatic brain injury. Brain Research, 1892, 150540. https://doi.org/10.1016/j.brainres.2026.150540

Vancouver

Capeci HE, Pivirotto CE, Steber JA, Vozzella VJ, Bittner RA, Santra P, et al. Differential effects of brexpiprazole on cognitive recovery and cortical lesion volume after experimental traumatic brain injury. Brain Research. 2026;1892:150540. doi:10.1016/j.brainres.2026.150540

BibTeX
@article{Capeci2026,
  author = {Capeci, Haley E and Pivirotto, Connor E and Steber, Jade A and Vozzella, Vincent J and Bittner, Rachel A and Santra, Prajeet and Cheng, Jeffrey P and Moschonas, Eleni H and Bondi, Corina O and Kline, Anthony E},
  title = {Differential effects of brexpiprazole on cognitive recovery and cortical lesion volume after experimental traumatic brain injury},
  journal = {Brain Research},
  year = {2026},
  volume = {1892},
  pages = {150540},
  doi = {10.1016/j.brainres.2026.150540}
}
Kostenlos starten →